Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva Pharma Gets Approval to Market Generic Nasal Spray for Opioid Overdoses - WSJ
Teva Pharma Appoints Novartis, Biogen Vet as New President and CEO | BioSpace
Teva Pharmaceuticals Lays Off Half Its Israeli Workers
Teva sells Overland Park business segment - Kansas City Business Journal
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma
Today's News: FBI Raids NY Yeshiva; Layoffs at Israel's Teva Pharmaceuticals; and more - Tablet Magazine
Opioid Lawsuit Against Teva Pharma
Teva Pharma CEO: We see a stable U.S. market place for our generics - YouTube
Teva bought the pharm, and now it may have bought the farm | The Times of Israel
Teva Pharmaceutical Industries Adds US$389m To Market Cap, But Investors Still Down 47% From Five Years Ago - Simply Wall St News
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceutical Industries (TEVA) Analysts Prediction, Stock Forecast & Price Targets - Simply Wall St
Teva Pharmaceuticals unchanged before hours on Q1 earnings beat - MassDevice
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum | AlphaStreet
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
teva News and latest stories | The Jerusalem Post
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
TEVA News Today | Why did Teva Pharmaceutical Industries stock go down today?
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Running out of time and money, CEO to prioritize getting Teva out of the hole | The Times of Israel
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
